AIM: The aim of our study was to evaluate the outcomes of patients reirradiated with high-dose-rate (HDR) intensity-modulated brachytherapy (IMBT) for recurrent head and neck cancer and to perform a systematic review of the literature. MATERIALS AND METHODS: Patients treated with prior radiation doses >65 Gy were considered. After resection of macroscopic disease, catheters were fixed to the tumor bed. The total dose was 30 Gy in 12 fractions of 2.5 Gy twice daily for 5 days a week. A systematic literature search was conducted through several electronic databases including Medline/PubMed, Scopus, Embase and the Cochrane library. RESULTS: Seventeen patients were included; median overall survival was 19 months with a median local control interval of 15 months. Median follow-up was 36 months. Seven papers were considered for the review. CONCLUSIONS: IMBT could play an important role in the retreatment of recurrent head and neck cancer.
AIM: The aim of our study was to evaluate the outcomes of patients reirradiated with high-dose-rate (HDR) intensity-modulated brachytherapy (IMBT) for recurrent head and neck cancer and to perform a systematic review of the literature. MATERIALS AND METHODS:Patients treated with prior radiation doses >65 Gy were considered. After resection of macroscopic disease, catheters were fixed to the tumor bed. The total dose was 30 Gy in 12 fractions of 2.5 Gy twice daily for 5 days a week. A systematic literature search was conducted through several electronic databases including Medline/PubMed, Scopus, Embase and the Cochrane library. RESULTS: Seventeen patients were included; median overall survival was 19 months with a median local control interval of 15 months. Median follow-up was 36 months. Seven papers were considered for the review. CONCLUSIONS:IMBT could play an important role in the retreatment of recurrent head and neck cancer.
Authors: Brandon S Imber; Suzanne L Wolden; Hilda E Stambuk; Evan Matros; Leonard H Wexler; Alexander S Drew; Evan B Rosen; Ian Ganly; Gil'ad N Cohen; Antonio L Damato Journal: Brachytherapy Date: 2019-02-22 Impact factor: 2.362
Authors: Andrea Alberti; Luigi Lorini; Marco Ravanelli; Francesco Perri; Marie Vinches; Paolo Rondi; Chiara Romani; Paolo Bossi Journal: Vaccines (Basel) Date: 2022-06-01
Authors: Luca Tagliaferri; Monica Maria Pagliara; Bruno Fionda; Andrea Scupola; Luigi Azario; Maria Grazia Sammarco; Rosa Autorino; Valentina Lancellotta; Silvia Cammelli; Carmela Grazia Caputo; Rafael Martinez-Monge; György Kovács; Maria Antonietta Gambacorta; Vincenzo Valentini; Maria Antonietta Blasi Journal: J Contemp Brachytherapy Date: 2019-02-28
Authors: Voichita Bar-Ad; Emily Hubley; Adam Luginbuhl; David Cognetti; Joseph Curry; Amy S Harrison; Jennifer M Johnson; James Keller; Cheng Peng; David To; Laura Doyle Journal: J Contemp Brachytherapy Date: 2019-06-28
Authors: Luca Tagliaferri; Ashwini Budrukkar; Jacopo Lenkowicz; Mauricio Cambeiro; Francesco Bussu; Jose Luis Guinot; Guido Hildebrandt; Bengt Johansson; Jens E Meyer; Peter Niehoff; Angeles Rovirosa; Zoltán Takácsi-Nagy; Luca Boldrini; Nicola Dinapoli; Vito Lanzotti; Andrea Damiani; Roberto Gatta; Bruno Fionda; Valentina Lancellotta; Tamer Soror; Rafael Martìnez Monge; Vincenzo Valentini; György Kovács Journal: J Contemp Brachytherapy Date: 2018-06-30